The UK stockmarket is an oblique window on the world. It contains many of the world's largest mining companies and a few of the largest oil producers.
There are companies selling booze and cigarettes, cough medicine and treatments for asthma. And in the undergrowth, only marginally influencing the path of the FTSE 100, are businesses buffeted by the domestic UK economy. In the current environment, most companies are finding it harder to grow, making normal management behaviour risky. In our view, a fast growing company can miss growth targets and allow costs to run ahead of new sales. Unpicking the risk/reward in healthcare stocks A slow growth company can be too slow to recognise disappointing sales or pricing is not fleetin...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes